Pityriasis Rosea after COVID-19 Infection

被引:0
作者
Prtajin, Marta [1 ]
Hadzavdic, Suzana Ljubojevic [1 ]
机构
[1] Univ Zagreb, Univ Hosp Ctr Zagreb, Sch Med, Dept Dermatol & Venereol, Zagreb, Croatia
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:265 / 266
页数:2
相关论文
共 11 条
[1]  
Atzori Laura, 2006, Dermatol Online J, V12, P1
[2]   Pityriasis rosea Gibert triggered by SARS-CoV-2 infection A case report [J].
Birlutiu, Victoria ;
Birlutiu, Rares Mircea ;
Iancu, Gabriela Mariana .
MEDICINE, 2021, 100 (14) :E25352
[3]   Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance [J].
Busto-Leis, J. M. ;
Servera-Negre, G. ;
Mayor-Ibarguren, A. ;
Sendagorta-Cudos, E. ;
Feito-Rodriguez, M. ;
Nuno-Gonzalez, A. ;
Montero-Vega, M. D. ;
Herranz-Pinto, P. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (08) :E489-E491
[4]  
Ciccarese G, 2017, J AM ACAD DERMATOL, V77, P4
[5]   Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature [J].
Drago, F. ;
Ciccarese, G. ;
Javor, S. ;
Parodi, A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (03) :544-545
[6]   Human herpesvirus-6,-7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19 [J].
Drago, Francesco ;
Ciccarese, Giulia ;
Rebora, Alfredo ;
Parodi, Aurora .
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) :1850-1851
[7]   Pityriasis Rosea: A Comprehensive Classification [J].
Drago, Francesco ;
Ciccarese, Giulia ;
Rebora, Alfredo ;
Broccolo, Francesco ;
Parodi, Aurora .
DERMATOLOGY, 2016, 232 (04) :431-437
[8]   Pityriasis rosea as a cutaneous manifestation of COVID-19 infection [J].
Ehsani, A. H. ;
Nasimi, M. ;
Bigdelo, Z. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (09) :E436-E437
[9]   Pityriasis rosea as a leading manifestation of COVID-19 infection [J].
Merhy, R. ;
Sarkis, A. S. ;
Stephan, F. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (04) :E246-E247
[10]   Prolonged dermatological manifestation 4 weeks following recovery of COVID-19 in a child [J].
Ng, Sze May .
BMJ CASE REPORTS, 2020, 13 (08)